Toscane Fourié

934 total citations
18 papers, 140 citations indexed

About

Toscane Fourié is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Modeling and Simulation. According to data from OpenAlex, Toscane Fourié has authored 18 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Public Health, Environmental and Occupational Health and 3 papers in Modeling and Simulation. Recurrent topics in Toscane Fourié's work include SARS-CoV-2 and COVID-19 Research (7 papers), Viral Infections and Vectors (7 papers) and Mosquito-borne diseases and control (7 papers). Toscane Fourié is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Viral Infections and Vectors (7 papers) and Mosquito-borne diseases and control (7 papers). Toscane Fourié collaborates with scholars based in France, United Kingdom and Mauritania. Toscane Fourié's co-authors include Isabelle Leparc-Goffart, Gilda Grard, Xavier de Lamballerie, Antoine Nougaırède, Läétitia Ninove, Sébastien Briolant, Maxime Cochin, Franck Touret, Audrey Dubot‐Pérès and Géraldine Piorkowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Toscane Fourié

17 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toscane Fourié France 8 117 55 14 13 11 18 140
Gene S. Tan United States 7 117 1.0× 29 0.5× 10 0.7× 5 0.4× 10 0.9× 14 176
Awadalkareem Adam United States 10 165 1.4× 156 2.8× 13 0.9× 6 0.5× 11 1.0× 26 239
Boyeong Ryu South Korea 6 91 0.8× 51 0.9× 22 1.6× 14 1.1× 2 0.2× 13 157
Yang Yuan China 6 144 1.2× 45 0.8× 34 2.4× 8 0.6× 6 0.5× 10 169
Priscilla Anti Germany 4 81 0.7× 29 0.5× 24 1.7× 17 1.3× 4 0.4× 6 122
Ohnmar Aung United States 5 69 0.6× 29 0.5× 13 0.9× 14 1.1× 14 1.3× 8 129
Pierina Lorencini Parise Brazil 6 64 0.5× 26 0.5× 12 0.9× 4 0.3× 6 0.5× 14 95
Nadina Wand United Kingdom 6 92 0.8× 32 0.6× 7 0.5× 25 1.9× 8 149
Bernard Lubwama Uganda 5 76 0.6× 77 1.4× 19 1.4× 22 1.7× 2 0.2× 7 113
Seung‐Gyu Jang South Korea 6 112 1.0× 8 0.1× 8 0.6× 9 0.7× 12 1.1× 11 157

Countries citing papers authored by Toscane Fourié

Since Specialization
Citations

This map shows the geographic impact of Toscane Fourié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toscane Fourié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toscane Fourié more than expected).

Fields of papers citing papers by Toscane Fourié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toscane Fourié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toscane Fourié. The network helps show where Toscane Fourié may publish in the future.

Co-authorship network of co-authors of Toscane Fourié

This figure shows the co-authorship network connecting the top 25 collaborators of Toscane Fourié. A scholar is included among the top collaborators of Toscane Fourié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toscane Fourié. Toscane Fourié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Fourié, Toscane, Guillaume André Durand, Franck Touret, et al.. (2023). Molecular characterization of dengue virus serotype 1 infections in French travelers from Africa between 2013 and 2019. SHILAP Revista de lepidopterología. 3. 4 indexed citations
3.
Taylor, John D., et al.. (2023). Evidence for some antimicrobial properties of English churchyard lichens. Access Microbiology. 5(6). 3 indexed citations
4.
Masse, Shirley, Lisandru Capai, Toscane Fourié, et al.. (2022). A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France). International Journal of Environmental Research and Public Health. 19(4). 1953–1953. 1 indexed citations
5.
Masse, Shirley, Lisandru Capai, Toscane Fourié, et al.. (2022). Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population. International Journal of Environmental Research and Public Health. 19(22). 15257–15257. 1 indexed citations
6.
Warszawski, Josiane, Laurence Meyer, Jeanna-Eve Franck, et al.. (2022). Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV. PLoS ONE. 17(5). e0267725–e0267725. 12 indexed citations
7.
Piorkowski, Géraldine, Franck Touret, Toscane Fourié, et al.. (2022). A simple reverse genetics method to generate recombinant coronaviruses. EMBO Reports. 23(5). e53820–e53820. 26 indexed citations
8.
Fourié, Toscane, Guillaume Lano, Paola Mariela Saba Villarroel, et al.. (2021). Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients. Clinical Kidney Journal. 14(10). 2239–2245. 9 indexed citations
9.
Pezzı, Laura, Magali Gilles, Paola Mariela Saba Villarroel, et al.. (2021). Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°C. Vector-Borne and Zoonotic Diseases. 21(12). 989–993. 1 indexed citations
10.
Rico, Audrey, Läétitia Ninove, Adil Maarouf, et al.. (2021). Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(4). 3080425342–3080425342. 5 indexed citations
11.
Fourié, Toscane, Audrey Dubot‐Pérès, Gilda Grard, et al.. (2021). Emergence of dengue virus serotype 2 in Mauritania and molecular characterization of its circulation in West Africa. PLoS neglected tropical diseases. 15(10). e0009829–e0009829. 16 indexed citations
12.
Fourié, Toscane, Aïssata Dia, Vincent Pommier de Santi, et al.. (2021). Emergence of Indian lineage of ECSA chikungunya virus in Djibouti, 2019. International Journal of Infectious Diseases. 108. 198–201. 6 indexed citations
13.
Robert, Thomas, Guillaume Lano, Toscane Fourié, et al.. (2021). Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders. Nephrology Dialysis Transplantation. 37(2). 390–392. 11 indexed citations
14.
Capai, Lisandru, Shirley Masse, Toscane Fourié, et al.. (2021). Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People. Frontiers in Public Health. 9. 715192–715192. 2 indexed citations
15.
Fourié, Toscane, Léa Lucıanı, Sophie Amrane, et al.. (2020). Dengue Virus Type 1 Infection in Traveler Returning from Benin to France, 2019. Emerging infectious diseases. 26(8). 1946–1949. 10 indexed citations
16.
Javelle, Émilie, Gilda Grard, Aïssata Dia, et al.. (2019). Tracking Rift Valley fever: From Mali to Europe and other countries, 2016. Eurosurveillance. 24(8). 21 indexed citations
17.
Taylor, John D. & Toscane Fourié. (2019). Antimicrobial properties from lichens: An evaluation of the antimicrobial properties of English churchyard lichens. Access Microbiology. 1(10). 1 indexed citations
18.
Fourié, Toscane, et al.. (2018). Variability of Zika Virus Incubation Period in Humans. Open Forum Infectious Diseases. 5(11). ofy261–ofy261. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026